327 related articles for article (PubMed ID: 31329924)
1. Chromoblastomycosis in the Amazon region, Brazil, caused by Fonsecaea pedrosoi, Fonsecaea nubica, and Rhinocladiella similis: Clinicopathology, susceptibility, and molecular identification.
de Andrade TS; de Almeida AMZ; Basano SA; Takagi EH; Szeszs MW; Melhem MSC; Albuquerque M; Camargo JSAA; Gambale W; Camargo LMA
Med Mycol; 2020 Feb; 58(2):172-180. PubMed ID: 31329924
[TBL] [Abstract][Full Text] [Related]
2. Molecular identification and antifungal susceptibility profiles of clinical strains of Fonsecaea spp. isolated from patients with chromoblastomycosis in Rio de Janeiro, Brazil.
Coelho RA; Brito-Santos F; Figueiredo-Carvalho MHG; Silva JVDS; Gutierrez-Galhardo MC; do Valle ACF; Zancopé-Oliveira RM; Trilles L; Meyer W; Freitas DFS; Almeida-Paes R
PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006675. PubMed ID: 30048450
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic and molecular identification of Fonsecaea pedrosoi strains isolated from chromoblastomycosis patients in Mexico and Venezuela.
Carolina Rojas O; León-Cachón RB; Pérez-Maya AA; Aguirre-Garza M; Moreno-Treviño MG; González GM
Mycoses; 2015 May; 58(5):267-72. PubMed ID: 25728464
[TBL] [Abstract][Full Text] [Related]
4. Chromoblastomycosis caused by Fonsecaea: clinicopathology, susceptibility and molecular identification of seven consecutive cases in Southern China.
Yang YP; Li W; Huang WM; Zhou Y; Fan YM
Clin Microbiol Infect; 2013 Nov; 19(11):1023-8. PubMed ID: 23153454
[TBL] [Abstract][Full Text] [Related]
5. An impressive case of chromoblastomycosis due to Fonsecaea pedrosoi in a patient with a long history of fungal infection.
Romero-Navarrete M; Ruíz LF; Castillo A; Arenas R; Vega-Memije ME; Xicohtencatl-Cortes J; Espinoza-Rivera M; Hernández-Castro R
J Mycol Med; 2018 Dec; 28(4):663-665. PubMed ID: 30126716
[TBL] [Abstract][Full Text] [Related]
6. Molecular Epidemiology of Agents of Human Chromoblastomycosis in Brazil with the Description of Two Novel Species.
Gomes RR; Vicente VA; Azevedo CM; Salgado CG; da Silva MB; Queiroz-Telles F; Marques SG; Santos DW; de Andrade TS; Takagi EH; Cruz KS; Fornari G; Hahn RC; Scroferneker ML; Caligine RB; Ramirez-Castrillon M; de Araújo DP; Heidrich D; Colombo AL; de Hoog GS
PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005102. PubMed ID: 27893750
[TBL] [Abstract][Full Text] [Related]
7. A case of relapsed chromoblastomycosis due to Fonsecaea monophora: antifungal susceptibility and phylogenetic analysis.
Daboit TC; Magagnin CM; Heidrich D; Castrillón MR; Mendes SD; Vettorato G; Valente P; Scroferneker ML
Mycopathologia; 2013 Aug; 176(1-2):139-44. PubMed ID: 23645135
[TBL] [Abstract][Full Text] [Related]
8. Molecular epidemiology and clinical-laboratory aspects of chromoblastomycosis in Mato Grosso, Brazil.
Guevara A; Nery AF; de Souza Carvalho Melhem M; Bonfietti L; Rodrigues AM; Hagen F; de Carvalho JA; de Camargo ZP; de Souza Lima BJF; Vicente VA; Hahn RC
Mycoses; 2022 Dec; 65(12):1146-1158. PubMed ID: 35869803
[TBL] [Abstract][Full Text] [Related]
9. Chromoblastomycosis Caused by Fonsecaea nubica: First Report in Northern China and Literature Review.
You Z; Yang X; Yu J; Zhang J; Ran Y
Mycopathologia; 2019 Feb; 184(1):97-105. PubMed ID: 30547378
[TBL] [Abstract][Full Text] [Related]
10. Chromoblastomycosis due to Fonsecaea pedrosoi and F. monophora in Cuba.
Badali H; Fernández-González M; Mousavi B; Illnait-Zaragozi MT; González-Rodríguez JC; de Hoog GS; Meis JF
Mycopathologia; 2013 Jun; 175(5-6):439-44. PubMed ID: 23471535
[TBL] [Abstract][Full Text] [Related]
11. Molecular identification of chromoblastomycosis clinical isolates in Guangdong.
Fransisca C; He Y; Chen Z; Liu H; Xi L
Med Mycol; 2017 Nov; 55(8):851-858. PubMed ID: 28053146
[TBL] [Abstract][Full Text] [Related]
12. A case of chromoblastomycosis by Fonsecaea nubica indicating a possible insect route of transmission.
Chen Y; Yin S; Li M; Chen R; Wei L; Ma H; Deng S; de Hoog GS; Lai W; Lu C; Feng P
Mycoses; 2016 Oct; 59(10):662-7. PubMed ID: 27330038
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of sequential Fonsecaea pedrosoi isolates from chromoblastomycosis patients to antifungal agents.
Andrade TS; Castro LG; Nunes RS; Gimenes VM; Cury AE
Mycoses; 2004 Jun; 47(5-6):216-21. PubMed ID: 15189187
[TBL] [Abstract][Full Text] [Related]
14. Chromoblastomycosis caused by Fonsecaea monophora in Mexico.
Campos-Macias P; Arenas R; Aquino CJ; Romero-Navarrete M; Martínez-Hernández F; Martínez-Chavarría LC; Xicohtencatl-Cortes J; Hernández-Castro R
J Mycol Med; 2021 Jun; 31(2):101114. PubMed ID: 33684836
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effect of terbinafine and amphotericin B in killing Fonsecaea nubica in vitro and in vivo.
Zhang J; Wu X; Li M; Huang J; Yin S; Huang H; Lu C; Xi L
Rev Inst Med Trop Sao Paulo; 2019 Jun; 61():e31. PubMed ID: 31241660
[TBL] [Abstract][Full Text] [Related]
16. Endemic Chromoblastomycosis Caused Predominantly by Fonsecaea nubica, Madagascar
Rasamoelina T; Maubon D; Andrianarison M; Ranaivo I; Sendrasoa F; Rakotozandrindrainy N; Rakotomalala FA; Bailly S; Rakotonirina B; Andriantsimahavandy A; Rabenja FR; Andrianarivelo MR; Cornet M; Ramarozatovo LS
Emerg Infect Dis; 2020 Jun; 26(6):1201-1211. PubMed ID: 32441639
[TBL] [Abstract][Full Text] [Related]
17. Fonsecaea nubica sp. nov, a new agent of human chromoblastomycosis revealed using molecular data.
Najafzadeh MJ; Sun J; Vicente V; Xi L; van den Ende AH; de Hoog GS
Med Mycol; 2010 Sep; 48(6):800-6. PubMed ID: 20302550
[TBL] [Abstract][Full Text] [Related]
18. Combination of Amphotericin B and Terbinafine against Melanized Fungi Associated with Chromoblastomycosis.
Deng S; Lei W; de Hoog GS; Yang L; Vitale RG; Rafati H; Seyedmousavi M; Tolooe A; van der Lee H; Liao W; Verweij PE; Seyedmousavi S
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29581111
[TBL] [Abstract][Full Text] [Related]
19. In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp.
Najafzadeh MJ; Badali H; Illnait-Zaragozi MT; De Hoog GS; Meis JF
Antimicrob Agents Chemother; 2010 Apr; 54(4):1636-8. PubMed ID: 20086140
[TBL] [Abstract][Full Text] [Related]
20. Antifungal therapy in an athymic murine model of chromoblastomycosis by Fonsecaea pedrosoi.
Calvo E; Pastor FJ; Mayayo E; Hernández P; Guarro J
Antimicrob Agents Chemother; 2011 Aug; 55(8):3709-13. PubMed ID: 21576429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
